Effect of Covid-19 on Caregivers of Persons with Dementia
Covid-19 对痴呆症患者照顾者的影响
基本信息
- 批准号:10220410
- 负责人:
- 金额:$ 44.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgitationAlzheimer&aposs DiseaseAlzheimer&aposs disease caregiverAlzheimer&aposs disease patientAssisted Living FacilitiesBehaviorBehavioralCOVID-19COVID-19 pandemicCaregiver BurdenCaregiversCaringCommunicable DiseasesCommunitiesContinuity of Patient CareDeath RateDecision MakingDementiaDronabinolElderlyEmploymentFamilyFamily CaregiverFamily RelationshipFibrinogenFormal caregiverGoalsGuidelinesHealthHealthcareHealthcare SystemsHomeInfection ControlInstitutesInterviewLong-Term CareMethodsMorbidity - disease rateNatureNursing HomesOutpatientsPatient CarePatientsPersonal SatisfactionPersonsProceduresQuarantineRandomized Controlled TrialsRoleSeveritiesShelter facilityStressStructureTimeVaccinesWorkbehavior changecaregivingexperienceinfection riskinformal caregivermortalitypandemic diseaserisk mitigationstressor
项目摘要
The US and its healthcare systems are experiencing an unprecedented crisis through the
COVID-19 pandemic that is having a major impact on PWD, their family caregivers, and the
front- line professional staff who support them. In many communities, death rates from COVID-
19 disproportionately involve older adults and PWD, especially those living in assisted living
facilities and nursing homes. Health workers in these facilities, and caring for older adults at
home, are also at risk of infection, morbidity and even mortality.Infection control guidelines and
mandates have shut down institutional access to visitors and instituted quarantining procedures
that further isolate PWD. Lack of structured activities, sheltering in place, caregiver stressors
around employment, finances, and risk mitigation all have the potential to exacerbate behavioral
issues in PWD. The nature of the pandemic also creates the need for urgent, real-time decision-
making, in the face of an evolving infectious disease that is highly communicable, leads to
unpredictable and precipitous declines and for which there is no cure or vaccine.
Specific Aims:
The goal of this study is to engage family and professional (CNAs,LPNs, RNs) caregivers of
PWD across the care continuum (nursing homes, assisted living facilities, and in the community)
to study the impact of COVID-19 on the health and well-being of PWD and their caregivers, the
caregiving experience and the impact of COVID-19 on patient behaviors and work/family
relationships. Through a mixed-methods study involving 600 formal and informal caregivers of
PWD residing in the community, in assisted living facilities (ALF) and nursing homes, we will
accomplish this goal through the following aims:
Aim 1: Describe the caregiver lived experience during the COVID-19 pandemic
Aim 2: Examine how COVID-19 related factors (including quarantining, isolation, etc.) have
affected caregiver stress.
Aim 3: Explore the role of COVD-19 related factors (i.e., PPE, caregiver stress) on behavior
changes and severity in PWD.
Aim 4: Assess the impact of COVID-19 on caregiver planning and health care decision-making
美国及其医疗保健系统正在经历一场前所未有的危机
COVID-19 大流行对残疾人及其家庭护理人员和社区产生了重大影响
支持他们的一线专业人员。在许多社区,新冠肺炎导致的死亡率
19 不成比例地涉及老年人和残疾人,特别是那些生活在辅助生活中的人
设施和疗养院。这些设施中的卫生工作者以及在这些设施中照顾老年人的人员
在家中,也面临感染、发病甚至死亡的风险。感染控制指南和
任务规定关闭了机构对访客的准入并制定了隔离程序
进一步隔离残疾人。缺乏结构化活动、就地庇护、护理人员压力
围绕就业、财务和风险缓解的所有方面都有可能加剧行为
PWD 中的问题。大流行的性质也需要做出紧急、实时的决策——
面对一种高度传染性的不断演变的传染病,导致
不可预测的急剧下降,并且没有治愈方法或疫苗。
具体目标:
本研究的目标是让家庭和专业(CNA、LPN、RN)护理人员参与
整个护理过程中的残疾人(疗养院、辅助生活设施和社区)
为了研究 COVID-19 对残疾人及其护理人员的健康和福祉的影响,
护理经验以及 COVID-19 对患者行为和工作/家庭的影响
关系。通过一项涉及 600 名正式和非正式护理人员的混合方法研究
居住在社区、辅助生活设施 (ALF) 和疗养院的残疾人,我们将
通过以下目标实现这一目标:
目标 1:描述 COVID-19 大流行期间看护者的生活经历
目标 2:检查 COVID-19 相关因素(包括隔离、隔离等)如何影响
影响照顾者的压力。
目标 3:探索 COVD-19 相关因素(即 PPE、护理人员压力)对行为的作用
PWD 的变化和严重程度。
目标 4:评估 COVID-19 对护理人员规划和医疗保健决策的影响
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cannabinoids for Agitation in Alzheimer's Disease.
- DOI:10.1016/j.jagp.2021.01.015
- 发表时间:2021-12
- 期刊:
- 影响因子:0
- 作者:Outen JD;Burhanullah MH;Vandrey R;Amjad H;Harper DG;Patrick RE;May RL;Agronin ME;Forester BP;Rosenberg PB
- 通讯作者:Rosenberg PB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent Peter Forester其他文献
Brent Peter Forester的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brent Peter Forester', 18)}}的其他基金
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10411985 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10224086 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
9788999 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
10170190 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9104639 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9706077 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8016112 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8424297 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8214530 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
7582632 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
相似国自然基金
欧拉描述下求粘弹塑性材料残余应力和自由边界的有限元方法
- 批准号:11302051
- 批准年份:2013
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Innovative Chair to Prevent Pressure Injuries in Persons Living with Alzheimer's Disease and Related Dementias
预防阿尔茨海默病和相关痴呆症患者压力损伤的创新椅子
- 批准号:
10760048 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
P38 α激酶抑制剂 Neflamapimod 治疗轻至中度路易体痴呆 (DLB) 患者的 2b 期临床研究
- 批准号:
10582488 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Behavioral and Molecular Consequences of Tau Pathology in Locus Coeruleus in Prodromal Alzheimer's Disease
阿尔茨海默病前驱期蓝斑 Tau 蛋白病理学的行为和分子后果
- 批准号:
10604890 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Assess Neural Circuits and Subtypes Underlying Dimensions of Neuropsychiatric Symptoms in Alzheimer's Disease
评估阿尔茨海默病神经精神症状的神经回路和亚型
- 批准号:
10741906 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Research Network to Accelerate Mechanistic Studies of Music for Dementia (RN-MusD)
加速音乐治疗痴呆症机制研究的研究网络 (RN-MusD)
- 批准号:
10764090 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别: